286 related articles for article (PubMed ID: 32414595)
21. Activations of mitogen-activated protein kinases and regulation of their downstream molecules after rat lung transplantation from donors after cardiac death.
Yamamoto S; Yamane M; Yoshida O; Okazaki M; Waki N; Toyooka S; Oto T; Miyoshi S
Transplant Proc; 2011 Dec; 43(10):3628-33. PubMed ID: 22172817
[TBL] [Abstract][Full Text] [Related]
22. JUN Amino-Terminal Kinase 1 Signaling in the Proximal Tubule Causes Cell Death and Acute Renal Failure in Rat and Mouse Models of Renal Ischemia/Reperfusion Injury.
Grynberg K; Ozols E; Mulley WR; Davis RJ; Flavell RA; Nikolic-Paterson DJ; Ma FY
Am J Pathol; 2021 May; 191(5):817-828. PubMed ID: 33607044
[TBL] [Abstract][Full Text] [Related]
23. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
24. Intratracheal administration of p38α short-hairpin RNA plasmid ameliorates lung ischemia-reperfusion injury in rats.
Lv X; Tan J; Liu D; Wu P; Cui X
J Heart Lung Transplant; 2012 Jun; 31(6):655-62. PubMed ID: 22503847
[TBL] [Abstract][Full Text] [Related]
25. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs.
Ishii M; Suzuki Y; Takeshita K; Miyao N; Kudo H; Hiraoka R; Nishio K; Sato N; Naoki K; Aoki T; Yamaguchi K
J Immunol; 2004 Feb; 172(4):2569-77. PubMed ID: 14764730
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
[TBL] [Abstract][Full Text] [Related]
29. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
30. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
Abdelli S; Bonny C
PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
[TBL] [Abstract][Full Text] [Related]
31. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
[TBL] [Abstract][Full Text] [Related]
32. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
[TBL] [Abstract][Full Text] [Related]
33. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.
David JP; Sabapathy K; Hoffmann O; Idarraga MH; Wagner EF
J Cell Sci; 2002 Nov; 115(Pt 22):4317-25. PubMed ID: 12376563
[TBL] [Abstract][Full Text] [Related]
34. Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.
Lu W; Liu Y; Gao Y; Geng Q; Gurbani D; Li L; Ficarro SB; Meyer CJ; Sinha D; You I; Tse J; He Z; Ji W; Che J; Kim AY; Yu T; Wen K; Anderson KC; Marto JA; Westover KD; Zhang T; Gray NS
J Med Chem; 2023 Mar; 66(5):3356-3371. PubMed ID: 36826833
[TBL] [Abstract][Full Text] [Related]
35. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.
Prause M; Mayer CM; Brorsson C; Frederiksen KS; Billestrup N; Størling J; Mandrup-Poulsen T
J Diabetes Res; 2016; 2016():1312705. PubMed ID: 26962537
[TBL] [Abstract][Full Text] [Related]
36. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.
Zhong S; Fromm J; Johnson DL
Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
[TBL] [Abstract][Full Text] [Related]
38. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2.
Takatori A; Geh E; Chen L; Zhang L; Meller J; Xia Y
Development; 2008 Jan; 135(1):23-32. PubMed ID: 18032450
[TBL] [Abstract][Full Text] [Related]
39. Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors.
Pietkiewicz S; Sohn D; Piekorz RP; Grether-Beck S; Budach W; Sabapathy K; Jänicke RU
PLoS One; 2013; 8(4):e61438. PubMed ID: 23593480
[TBL] [Abstract][Full Text] [Related]
40. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.
Prause M; Christensen DP; Billestrup N; Mandrup-Poulsen T
PLoS One; 2014; 9(1):e87067. PubMed ID: 24475223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
